Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.
about
High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in PakistanThe impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.Viral infections during pregnancyEstimating past hepatitis C infection risk from reported risk factor histories: implications for imputing age of infection and modeling fibrosis progressionThe Role of Obstetrician/Gynecologists in the Management of Hepatitis C Virus InfectionPrevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican cities bordering the U.SHepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infectionIncidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infectionPrevalence of HIV, Hepatitis B and C Infections and an Assessment of HCV-Genotypes and Two IL28B SNPs among People Who Inject Drugs in Three Regions of NepalAgent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C InfectionsPrevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working?Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto RicoA national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design.A trial to reduce hepatitis C seroincidence in drug users.Risk factors for hepatitis C seropositivity among young people who inject drugs in New York City: Implications for preventionRisk of hepatitis B infection among young injection drug users in San Francisco: opportunities for intervention.The societal cost of heroin use disorder in the United States.Prevalence and incidence of HCV infection among Vietnam heroin users with recent onset of injection.HIV/hepatitis prevention in drug abuse treatment programs: guidance from researchCircumstances, pedagogy and rationales for injection initiation among new drug injectors.Potential impact of vaccination on the hepatitis C virus epidemic in injection drug users.Prevalence and correlates of Hepatitis C among injection drug users: The significance of duration of use, incarceration and race/ethnicity.Chronic pain and hepatitis C virus infection in opioid dependent injection drug usersHarm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, CaliforniaAcute hepatitis C virus infection in incarcerated injection drug users.Prescription opioid injection and risk of hepatitis C in relation to traditional drugs of misuse in a prospective cohort of street youthSyringe availability as HIV prevention: a review of modalities.Seroprevalence of Hepatitis B, Hepatitis C and Human Immunodeficiency viruses amongst Injecting Drug Users in Mumbai,India.Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US citiesRisk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review.Hepatitis C management by addiction medicine physicians: results from a national surveyThe perceived consequences of safer injection: an exploration of qualitative findings and gender differencesHepatitis C virus infection is associated with painful symptoms in HIV-infected adults.Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremiaHepatitis C virus infection in the human immunodeficiency virus infected patient.Injection drug use among stimulant users in a national sampleSyringe exchange programs: lowering the transmission of syringe-borne diseases and beyondThe role of needle exchange programs in HIV prevention.Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
P2860
Q24673331-F80109B7-B881-4CAA-8CF9-53A080CC798EQ24811537-D6E4AAF4-2C76-48B7-9009-7FB46B2C4CB4Q27027087-B08416CA-C34B-4534-97CF-DB0F48C7DD95Q27485372-01D09380-2C77-4E7A-B26D-E94E714CD4C4Q27486939-01FF321D-9D9F-4481-B3B0-1B29F3FAEE1FQ27489610-974F20D2-E3C5-4DB5-ABE5-0F88898E1DA0Q27490176-8A86CF8A-E9B5-4EB3-9930-B2168507F790Q28361460-52F27D6A-616F-40E0-AB88-F617EF693A68Q28547151-D0BF9825-B3CF-4D89-A3CB-A6FAAD4B7C5FQ28548643-DCD474C5-A04E-4725-8ADF-704E6D3D7805Q28768135-8609E2D8-34C3-4193-8FAF-CF30128FA018Q33262182-5D0DBD96-F728-4722-8802-71EA5634794FQ33483115-3D7FBF86-0D66-435D-B138-EAD5E24866FCQ33658861-99615676-195C-4C77-96E1-E96F7A9C2539Q33707925-3660FCDB-60C9-430A-8835-F6694FF8D21AQ33727105-59665991-6B08-4952-9135-7EE8A2907BD0Q33739154-40057E62-3E8B-45FF-AE1E-76E699C19E94Q33754364-F2BAB96B-81FD-41DC-B4F5-10729862F87EQ33774978-E99F43F0-5DE6-4B24-8920-B338B80DD4A2Q33824129-5E9C2F51-1CEF-4EC2-AE6E-0D502E642D38Q33824723-41BCD74C-442E-4050-B025-0DC5C95FDAEAQ33840231-C46E099B-3328-4EC8-A5CE-40679FEF1505Q33872397-C178F964-A801-45E7-97A4-5A218094E7E1Q33938301-74FFD8AA-6D96-4B45-93AC-DD882E92ABBFQ33968846-52B55525-0F9B-4B91-A50B-46DDB001745BQ33995930-7E1563AE-2116-4018-951A-343AEF7ABD8BQ33996279-C4C920BB-8552-4527-9D44-FDE97F15025BQ34025172-78775AB5-2240-4614-B6C1-FFA5FDF9AAA3Q34030468-6411C81C-EE5F-4827-97AE-2D572DF9A79CQ34067472-87E39B1B-9917-427B-8D0D-62850AB53C79Q34088235-7D31D03A-867B-4A9E-962B-B4AE0F8D1E14Q34090853-BBD93ED6-7CE3-4DC8-A6E7-707D71F88BE8Q34129074-F5EB7E91-345A-413F-B51F-DB834C1205D6Q34137925-34C7EACF-E908-4781-BC30-72A21561D651Q34158520-8CFC0C57-BF54-4DA0-9578-B6526647F8C0Q34168504-09F69A66-3444-4ABA-8965-5A8F88591950Q34195746-03C9E500-F209-463B-908E-F5522B1623C7Q34196397-8070D1BA-2FA9-4B8E-91C2-1486DECFC454Q34196402-3494152B-3C92-43F2-A10F-AEDE428428B1Q34196408-13ADC32B-94F8-4155-B5E2-D575BC70B3F3
P2860
Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Viral infections in short-term ...... human T-lymphotropic viruses.
@en
Viral infections in short-term ...... human T-lymphotropic viruses.
@nl
type
label
Viral infections in short-term ...... human T-lymphotropic viruses.
@en
Viral infections in short-term ...... human T-lymphotropic viruses.
@nl
prefLabel
Viral infections in short-term ...... human T-lymphotropic viruses.
@en
Viral infections in short-term ...... human T-lymphotropic viruses.
@nl
P2093
P356
P1476
Viral infections in short-term ...... human T-lymphotropic viruses.
@en
P2093
P304
P356
10.2105/AJPH.86.5.655
P407
P577
1996-05-01T00:00:00Z